Old Web
English
Sign In
Acemap
>
authorDetail
>
Frank S. Czerwiec
Frank S. Czerwiec
Diabetes mellitus
Endocrinology
Medicine
Internal medicine
Placebo
4
Papers
1022
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: The TEMPO 4:4 Trial
2017
Nephrology Dialysis Transplantation
Vicente E. Torres
Arlene B. Chapman
Olivier Devuyst
Ron T. Gansevoort
Ronald D. Perrone
Ann Dandurand
John Ouyang
Frank S. Czerwiec
Jaime D. Blais
Tempo : Trial Investigators
Show All
Source
Cite
Save
Citations (75)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
2012
The New England Journal of Medicine
Vicente E. Torres
Arlene B. Chapman
Olivier Devuyst
Ron T. Gansevoort
Jared J. Grantham
Eiji Higashihara
Ronald D. Perrone
Holly B. Krasa
John Ouyang
Frank S. Czerwiec
Show All
Source
Cite
Save
Citations (927)
Visualization of Fibrous Dysplasia During Somatostatin Receptor Scintigraphy
1998
The Journal of Nuclear Medicine
Clara C. Chen
Frank S. Czerwiec
Penelope Feuillan
Show All
Source
Cite
Save
Citations (20)
Modern approach to corticosteroid replacement therapy
1996
Current Opinion in Endocrinology & Diabetes
Frank S. Czerwiec
Gordon B. Cutler
Show All
Source
Cite
Save
Citations (0)
1